Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
PR April 9th āIn other news, the Company will commence Scientific Advice discussions with the European Medicines Agency (EMA) this week, via a scheduled meeting, to review plans for the international Phase 3 Brilacidin Oral Mucositis program.ā This week meaning the week of April 9th.
āWhy would anyone spend time bashing. company selling for .15ā thatās a great question whatās the answer?
No I am very serious unlikely many here. You probably donāt know to many people who are high level consultants at small to medium sized companies but they certainly do command near 7 figure yearly compensation.
Total bs he could easily make that as a consultant.
Who paid for it?
Which company in the article paid for the piece?
Nice write up! Thanks for sharing!
Leo continues to tell us in each pr what they are doing to move the company forward. I would like him to answer the financing question soon but if you are an investor that follows this stock on an hourly basis and only complain about the ceo you are either a liar or a terrible investor!
New European subsidiary and recent European submission for B-OM! Very exciting times ahead.
Awesome news! Congrats I have one on the 25th
āI'm aware of the potential upside and agreements and all of that stuffā So you read all about the drug potential but you missed the last 10q that said we need to find financing by the end of March. I doubt it. Nice try!
As long as your source isnāt the sales department! Lol!
āI would have to be a total idiot to continue holding shares if I believed IPIX is a scam. ā Only fake investors continue to hold fake shares and bitch about it on Anonymous chat boards.
I think some else had exactly the same thoughts! Lol
What does your contact in the sales department say?
āB has had patent protection for years now. ā protection for years is very valuable. Without it you very little value.
He could easily be a consultant and do just fine.
Again LE is the ceo therefore he makes the appointments to the board. If the president didnāt believe in the company or ceo he would just leave.
And why wouldnāt it. He was just appointed to the board so I am sure he is in agreement with the ceo.
Name one
āMy only point was that he's done and said a number of things that I believe were at the direction of the CEO. I don't know why, but I do know that his contract requires that he take his marching orders from the CEO. ā Of course you have no evidence. This statement is really beneath you! Lol! Does a president of a company every have more power/say than a ceo?!
Also doesnāt take in consideration off label use which could be big
Of course there isnāt! But dud told us he spoke with someone in the sales dept! Thatās what makes it so funny!
ā. I want to emphasize that this is not just an Agenus issue. Virtually without exception, small biotechnology companies are victimized by this wolfpack generated, investment banking firm abetted, scheme to defraud shareholders.ā This all sounds familiar!
Yes agreed having the treatment go from 7days to 1 is great but to have it in a pill form would be a game changer for sure.
Lol! Check out the website they have already completed a successful 2b Absssi study
So the notes wonāt show what the fda said in the meeting?
You said we only got one side of the story but the fda is going to show us what happened in the meeting so we should know what there side of the story is
āDon't expect to hear anything from the FDA. ā So we wonāt get the notes from the meeting?
āUnfortunately you're only going to get one side of that story and we already have the broad view of it: " itās the companies pr whoās side do you think your going to see and the fda is going to give us their side soon enough.
"Its been over a year since the Brilacidin phase 3 trials ended." I had no idea we had a phase 3 trial! Lol!
"Innovation Pharmaceuticals is preparing to seek scientific advice from the European Medicines Agency to round out European Union program requirements for Phase 3 clinical trials." Good news
Not a waste of time but at this piont I can't see a big difference between the 2 programs.
"Intensive guidance on an efficient drug development program and an
Organizational commitment involving FDA senior managers" Can you tell me exactly what this means? If the drug is already in phase 3 and has been granted fast track what is the benefit?
"those things apply to companies with a drug candidate that is granted a BTD." And to companies that are in phase1 or 2 with their drug. There seems to be little value for phase 3 drugs v fast track.
"PLUS
Intensive guidance on an efficient drug development program, beginning as early as Phase 1
Organizational commitment involving senior managers" Ipix B-OM was approved for phase 3 so how does this benefit us?
I am glad Dr B is on the board.
This will not be a $40 million study.
AF also works to manipulate the share price of the companies he writes about.